Wong H - Search Results

1

A comparative study of peri-operative outcomes for 100 consecutive post-chemotherapy and primary robot-assisted and open retroperitoneal lymph node dissections.

Lloyd P, Hong A, Furrer MA, Lee EWY, Dev HS, Coret MH, Adshead JM, Baldwin P, Knight R, Shamash J, Alifrangis C, Stoneham S, Mazhar D, Wong H, Warren A, Tran B, Lawrentschuk N, Neal DE, Thomas BC. Lloyd P, et al. Among authors: wong h. World J Urol. 2022 Jan;40(1):119-126. doi: 10.1007/s00345-021-03832-0. Epub 2021 Oct 1. World J Urol. 2022. PMID: 34599350

2

Adjuvant chemotherapy and follow-up for recurrences in localized testicular cancer.

Boulos S, Mazhar D, Warren AY, Wong HH. Boulos S, et al. Future Oncol. 2017 May;13(11):947-950. doi: 10.2217/fon-2017-0047. Future Oncol. 2017. PMID: 28481147 No abstract available.

3

Safety and Efficacy of Modified FOLFIRINOX for Advanced Pancreatic Adenocarcinoma: A UK Single-Centre Experience.

Ghorani E, Wong HH, Hewitt C, Calder J, Corrie P, Basu B. Ghorani E, et al. Oncology. 2015;89(5):281-7. doi: 10.1159/000439171. Epub 2015 Sep 16. Oncology. 2015. PMID: 26372905

4

Surgical resection of a massive primary mediastinal liposarcoma with cervical extension.

Weaver HL, Preston SD, Wong HH, Jani P, Coonar AS. Weaver HL, et al. Among authors: wong hh. Ann R Coll Surg Engl. 2018 Feb;100(2):e22-e27. doi: 10.1308/rcsann.2017.0163. Epub 2017 Nov 28. Ann R Coll Surg Engl. 2018. PMID: 29182001 Free PMC article.

5

Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literature.

Wong HH, Hatcher HM, Benson C, Al-Muderis O, Horan G, Fisher C, Earl HM, Judson I. Wong HH, et al. Clin Sarcoma Res. 2013 Nov 26;3(1):14. doi: 10.1186/2045-3329-3-14. Clin Sarcoma Res. 2013. PMID: 24280007 Free PMC article.

6

Lorlatinib for the treatment of inflammatory myofibroblastic tumour with TPM4-ALK fusion following failure of entrectinib.

Wong HH, Bentley H, Bulusu VR, Anyaegbu G, Watkins J, Horan G, Hatcher H. Wong HH, et al. Anticancer Drugs. 2020 Nov;31(10):1106-1110. doi: 10.1097/CAD.0000000000000994. Anticancer Drugs. 2020. PMID: 32868646

7

Trastuzumab beyond progression in advanced breast cancer: national guidance versus oncologist's decision.

Wong HH, Collins J, McAdam K, Wilson C. Wong HH, et al. Oncology. 2014;86(1):22-3. doi: 10.1159/000356876. Epub 2013 Dec 10. Oncology. 2014. PMID: 24335099 No abstract available.

8

Tivozanib for the treatment of metastatic renal cancer.

Wong HH, Eisen T. Wong HH, et al. Expert Rev Anticancer Ther. 2013 Jun;13(6):649-60. doi: 10.1586/era.13.40. Expert Rev Anticancer Ther. 2013. PMID: 23773100 Review.

9

Trends in the characteristics, dose-limiting toxicities and efficacy of phase I oncology trials: The Cancer Research UK experience.

Wong HH, Barton C, Acton G, McLeod R, Halford S. Wong HH, et al. Eur J Cancer. 2016 Oct;66:9-16. doi: 10.1016/j.ejca.2016.07.004. Epub 2016 Aug 8. Eur J Cancer. 2016. PMID: 27514008 Review.

10

Improving clinical trial recruitment: experience of a tertiary renal oncology centre.

Wong HH, Siegler C, Grainger S, Zaki KA, Matakidou A, Eisen T, Fife K. Wong HH, et al. Oncology. 2013;85(5):297-8. doi: 10.1159/000355688. Epub 2013 Nov 6. Oncology. 2013. PMID: 24217289 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,085 results

Search Page

Filters